MARONE, Romina, LANDMANN, Emmanuelle, DEVAUX, Anna, LEPORE, Rosalba, ROSITZKA, Julia, RHIEL, Manuel, GEOFFROY, Andrieux, CATHOMEN, Anton, CORNU, Tatjana I. und JEKER, Lukas T., 2023. Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy. Freiburg: Universität.
Elsevier - Harvard (with titles)Marone, R., Landmann, E., Devaux, A., Lepore, R., Rositzka, J., Rhiel, M., Geoffroy, A., Cathomen, A., Cornu, T.I., Jeker, L.T., 2023. Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy. Universität, Freiburg. https://doi.org/10.1084/jem.20231235
American Psychological Association 7th editionMarone, R., Landmann, E., Devaux, A., Lepore, R., Rositzka, J., Rhiel, M., Geoffroy, A., Cathomen, A., Cornu, T. I., & Jeker, L. T. (ca. 2023). Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy [Cd]. Universität. https://doi.org/10.1084/jem.20231235
Springer - Basic (author-date)Marone R, Landmann E, Devaux A, Lepore R, Rositzka J, Rhiel M, Geoffroy A, Cathomen A, Cornu TI, Jeker LT (2023) Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Marone, Romina/ Landmann, Emmanuelle/ Devaux, Anna/ Lepore, Rosalba/ Rositzka, Julia/ Rhiel, Manuel/ Geoffroy, Andrieux/ Cathomen, Anton/ Cornu, Tatjana I./ Jeker, Lukas T., Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy, Freiburg 2023.